Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 3
2022 2
2023 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting.
Keeley AJ, Camara FE, Armitage EP, de Crombrugghe G, Sillah J, Fofana ML, Rollinson V, Senghore E, Jammeh M, Whitcombe AL, Bittaye A, Ceesay H, Ceesay I, Samateh B, Manneh M, Carducci M, Rovetini L, Boero E, Massai L, Sanyang LC, Camara O, Cessay EE, Iturriza M, Moriel DG, Kucharski A, Smeesters PR, Botteaux A, Jagne YJ, Moreland NJ, Clarke E, Kampmann B, Marks M, Rossi O, Salje H, Turner CE, de Silva TI. Keeley AJ, et al. Among authors: fofana ml. Nat Med. 2025 Oct;31(10):3360-3371. doi: 10.1038/s41591-025-03868-4. Epub 2025 Aug 8. Nat Med. 2025. PMID: 40781379 Free PMC article.
Publisher Correction: Early-life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high-burden setting.
Keeley AJ, Camara FE, Armitage EP, de Crombrugghe G, Sillah J, Fofana ML, Rollinson V, Senghore E, Jammeh M, Whitcombe AL, Bittaye A, Ceesay H, Ceesay I, Samateh B, Manneh M, Carducci M, Rovetini L, Boero E, Massai L, Sanyang LC, Camara O, Cessay EE, Iturriza M, Moriel DG, Kucharski A, Smeesters PR, Botteaux A, Jagne YJ, Moreland NJ, Clarke E, Kampmann B, Marks M, Rossi O, Salje H, Turner CE, de Silva TI. Keeley AJ, et al. Among authors: fofana ml. Nat Med. 2025 Oct;31(10):3570. doi: 10.1038/s41591-025-04017-7. Nat Med. 2025. PMID: 40993244 Free PMC article. No abstract available.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Choi EM, Lacarra B, Afolabi MO, Ale BM, Baiden F, Bétard C, Foster J, Hamzé B, Schwimmer C, Manno D, D'Ortenzio E, Ishola D, Keita CM, Keshinro B, Njie Y, van Dijck W, Gaddah A, Anumendem D, Lowe B, Vatrinet R, Lawal BJ, Otieno GT, Samai M, Deen GF, Swaray IB, Kamara AB, Kamara MM, Diagne MA, Kowuor D, McLean C, Leigh B, Beavogui AH, Leyssen M, Luhn K, Robinson C, Douoguih M, Greenwood B, Thiébaut R, Watson-Jones D; EBOVAC-3/EBL2005 Study Team. Choi EM, et al. Lancet Glob Health. 2023 Nov;11(11):e1743-e1752. doi: 10.1016/S2214-109X(23)00410-2. Lancet Glob Health. 2023. PMID: 37858585 Free article. Clinical Trial.